Search Results - "Lang, Noemie"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    PET-adapted approaches to primary therapy for advanced Hodgkin lymphoma by Lang, Noemie, Crump, Michael

    Published in Therapeutic Advances in Hematology (01-06-2020)
    “…Recent results of randomized phase III studies of FDG-PET-adapted therapy for advanced Hodgkin lymphoma (HL) have clearly demonstrated benefit to alteration of…”
    Get full text
    Book Review Journal Article
  2. 2
  3. 3
  4. 4

    Case report: From sequence to solution: tailoring treatment for transformed follicular lymphoma (DLBCL) through next generation sequencing study by Bouroumeau, Antonin, Perdikis-Prati, Sarah, Lang, Noémie

    Published in Frontiers in oncology (29-02-2024)
    “…Immune checkpoint blockade (ICB) has indeed transformed the outlook for many advanced-stage solid tumors, yet its effectiveness in hematological malignancies…”
    Get full text
    Journal Article
  5. 5

    CAR T-Based Therapies in Lymphoma: A Review of Current Practice and Perspectives by Sheikh, Semira, Migliorini, Denis, Lang, Noémie

    Published in Biomedicines (01-08-2022)
    “…While more than half of non-Hodgkin lymphomas (NHL) can be cured with modern frontline chemoimmunotherapy regimens, outcomes of relapsed and/or refractory…”
    Get full text
    Journal Article
  6. 6

    Evolving management strategies for lymphomas during the COVID-19 pandemic by Lang, Noemie, Kuruvilla, John

    Published in Leukemia & lymphoma (16-04-2021)
    “…The evolving CoViD-19 pandemic has raised unprecedented challenges for physicians who face significant constraints in medical resources and cancer therapies…”
    Get full text
    Journal Article
  7. 7

    Efficacy of Immune Checkpoint Blockade and Biomarkers of Response in Lymphoma: A Narrative Review by Perdikis-Prati, Sarah, Sheikh, Semira, Bouroumeau, Antonin, Lang, Noémie

    Published in Biomedicines (01-06-2023)
    “…Immune checkpoint blockade (ICB) has revolutionized the prognosis of several advanced-stage solid tumors. However, its success has been far more limited in…”
    Get full text
    Journal Article
  8. 8

    Decision-Making among Experts in Advanced Hodgkin Lymphoma by Hitz, Felicitas, Lang, Noémie, Mey, Ulrich, Mingrone, Walter, Moccia, Alden, Taverna, Christian, Novak, Urban, Stenner, Frank, Schmidt, Adrian, Mamot, Christoph, Fischer, Natalie, Putora, Paul M

    Published in Oncology (01-03-2023)
    “…In the treatment of advanced Hodgkin lymphoma (aHL), based on guidelines a multitude of treatment options are available. The availability of PET-guided…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11

    Effectiveness of fractionated rituximab in preventing tumor lysis syndrome in aggressive B‐cell lymphoma: Insights from real‐life clinical practice by Mohamad, Jasmine, Bouroumeau, Antonin, McKee, Thomas A., Mach, Nicolas, Samii, Kaveh, Chamuleau, Martine, Stenner, Frank, Tamburini, Jerome, Lang, Noémie

    Published in Cancer reports (01-10-2024)
    “…Background Tumor lysis syndrome (TLS) is a potentially life‐threatening condition resulting from the rapid destruction of malignant cells, leading to…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences by Barreca, Marilia, Lang, Noémie, Tarantelli, Chiara, Spriano, Filippo, Barraja, Paola, Bertoni, Francesco

    “…Antibody-drug conjugates (ADCs) are a recent, revolutionary approach for malignancies treatment, designed to provide superior efficacy and specific targeting…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Post-transplant lymphoproliferative disorders by Forsell, Sabrina, Lang, Noémie

    Published in Revue médicale suisse (17-05-2023)
    “…Post-transplant lymphoproliferative disorders (PTLD) represent a typical complication of transplant recipients. Their incidence varies according to the…”
    Get more information
    Journal Article
  19. 19

    Monoclonal gammopathies: from MGUS to multiple myeloma by Thouvenin, Laure, Lang, Noémie

    Published in Revue médicale suisse (15-05-2019)
    “…Monoclonal plasma cell gammopathies (MPCG) describe several forms of abnormal plasma cell proliferation. Their prevalence increases with age. Initially…”
    Get more information
    Journal Article
  20. 20

    Progressive cutaneous and pulmonary lesions without infectious etiology: two cases reports of sweet syndrome with pulmonary involvement by Lang, Noémie, Vernez, Maxime, Vollenweider, Peter, Pasche, Antoine

    Published in Praxis (Bern. 1994) (17-09-2014)
    “…Sweet syndrome is a non infectious febrile disease with a neutrophilic infiltrate of dermis. Extracutaneous involvement can occur. We report two cases of Sweet…”
    Get more information
    Journal Article